204 related articles for article (PubMed ID: 38203404)
1. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Gavriilaki E; Bousiou Z; Batsis I; Vardi A; Mallouri D; Koravou EE; Konstantinidou G; Spyridis N; Karavalakis G; Noli F; Patriarcheas V; Masmanidou M; Touloumenidou T; Papalexandri A; Poziopoulos C; Yannaki E; Sakellari I; Politou M; Papassotiriou I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203404
[TBL] [Abstract][Full Text] [Related]
2. Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
Pedraza A; Salas MQ; Rodríguez-Lobato LG; Escribano-Serrat S; Suárez-Lledo M; Martínez-Cebrian N; Solano MT; Arcarons J; Rosiñol L; Gutiérrez-García G; Fernández-Avilés F; Moreno-Castaño AB; Molina P; Pino M; Carreras E; Díaz-Ricart M; Rovira M; Palomo M; Martínez C
Transplant Cell Ther; 2024 Feb; 30(2):187.e1-187.e12. PubMed ID: 38000709
[TBL] [Abstract][Full Text] [Related]
3. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation.
Koo J; Ziady AG; Reynaud D; Abdullah S; Luebbering N; Kahn S; Langenberg L; Strecker L; Lake K; Dandoy CE; Lane A; Myers KC; Sabulski A; Good S; Nalapareddy K; Solomon M; Siefert ME; Skala E; Jodele S; Davies SM
Transplant Cell Ther; 2023 Nov; 29(11):704.e1-704.e8. PubMed ID: 37625594
[TBL] [Abstract][Full Text] [Related]
4. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
Dandoy CE; Tsong WH; Sarikonda K; McGarvey N; Perales MA
Transplant Cell Ther; 2023 Apr; 29(4):282.e1-282.e9. PubMed ID: 36592719
[TBL] [Abstract][Full Text] [Related]
6. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
Yamada-Fujiwara M; Miyamura K; Fujiwara T; Tohmiya Y; Endo K; Onishi Y; Ishizawa K; Kameoka J; Ito M; Harigae H
Tohoku J Exp Med; 2012 May; 227(1):31-7. PubMed ID: 22531159
[TBL] [Abstract][Full Text] [Related]
8. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
9. A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD.
Furukawa M; Wang X; Ohkawara H; Fukatsu M; Alkebsi L; Takahashi H; Harada-Shirado K; Shichishima-Nakamura A; Kimura S; Ogawa K; Ikezoe T
Blood Adv; 2019 Jul; 3(14):2128-2143. PubMed ID: 31300420
[TBL] [Abstract][Full Text] [Related]
10. Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study.
Matsumura A; Miyazaki T; Tachibana T; Ando T; Koyama M; Koyama S; Ishii Y; Takahashi H; Nakajima Y; Numata A; Yamamoto W; Motohashi K; Hagihara M; Matsumoto K; Fujisawa S; Nakajima H
Turk J Haematol; 2020 Feb; 37(1):20-29. PubMed ID: 31464120
[TBL] [Abstract][Full Text] [Related]
11. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Mii A; Shimizu A; Kaneko T; Fujita E; Fukui M; Fujino T; Utsumi K; Yamaguchi H; Tajika K; Tsuchiya S; Iino Y; Katayama Y; Fukuda Y
Pathol Int; 2011 Sep; 61(9):518-27. PubMed ID: 21884301
[TBL] [Abstract][Full Text] [Related]
12. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
13. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
Front Immunol; 2021; 12():695037. PubMed ID: 34326846
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).
Mirna M; Rohm I; Jirak P; Wernly B; Bäz L; Paar V; Kretzschmar D; Hoppe UC; Schulze PC; Lichtenauer M; Jung C; Franz M
Heart Lung Circ; 2020 Mar; 29(3):337-344. PubMed ID: 31327702
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.
Labrador J; López-Corral L; López-Godino O; Vázquez L; Cabrero-Calvo M; Pérez-López R; Díez-Campelo M; Sánchez-Guijo F; Pérez-López E; Guerrero C; Alberca I; Del Cañizo MC; Pérez-Simón JA; González-Porras JR; Caballero D
Bone Marrow Transplant; 2014 May; 49(5):684-90. PubMed ID: 24566710
[TBL] [Abstract][Full Text] [Related]
16. Renal Complications after Hematopoietic Stem Cell Transplantation: Role of Graft-Versus-Host Disease in Renal Thrombotic Microangiopathy.
Mii A; Shimizu A; Yamaguchi H; Tsuruoka S
J Nippon Med Sch; 2020 Mar; 87(1):7-12. PubMed ID: 31776318
[TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase plasminogen activator receptor during allogeneic stem cell transplantation.
Haastrup E; Andersen J; Ostrowski SR; Høyer-Hansen G; Jacobsen N; Heilmann C; Ullum H; Müller K
Scand J Immunol; 2011 Apr; 73(4):325-9. PubMed ID: 21223347
[TBL] [Abstract][Full Text] [Related]
18. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure.
Jirak P; Fejzic D; Paar V; Wernly B; Pistulli R; Rohm I; Jung C; Hoppe UC; Schulze PC; Lichtenauer M; Yilmaz A; Kretzschmar D
Acta Pharmacol Sin; 2018 Jul; 39(7):1189-1196. PubMed ID: 29239349
[TBL] [Abstract][Full Text] [Related]
19. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
